Cyclopharm Limited (ASX:CYC)
Australia · Delayed Price · Currency is AUD 0.5050
-0.0050 (-0.98%)
Sep 2, 2026, 1:39 PM AEST
Cyclopharm Ratios and Metrics
Market cap in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 64 | 109 | 176 | 181 | 109 | 153 | |
Market Cap Growth | -41.42% | -38.17% | -2.75% | 66.37% | -28.90% | -23.69% |
Enterprise Value | 60 | 104 | 154 | 167 | 87 | 126 |
Last Close Price | 0.51 | 0.98 | 1.58 | 1.93 | 1.16 | 1.62 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 18.98 | 171.49 | 171.49 | 171.49 | 171.49 |
PS Ratio | 1.86 | 3.37 | 6.39 | 6.88 | 4.38 | 7.66 |
PB Ratio | 2.01 | 4.02 | 4.12 | 5.62 | 2.98 | 3.56 |
P/TBV Ratio | 2.18 | 4.32 | 4.68 | 6.63 | 3.41 | 3.98 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.73 | 3.23 | 5.59 | 6.35 | 3.49 | 6.31 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.25 | 0.29 | 0.19 | 0.13 | 0.12 | 0.11 |
Net Debt / Equity Ratio | -0.14 | 0.04 | -0.29 | -0.23 | -0.44 | -0.57 |
Net Debt / EBITDA Ratio | 0.27 | -0.07 | 0.90 | 0.80 | 2.98 | 5.90 |
Net Debt / FCF Ratio | 0.23 | -0.06 | 0.92 | 1.01 | 2.01 | 10.01 |
Asset Turnover | 0.65 | 0.60 | 0.51 | 0.55 | 0.47 | 0.48 |
Inventory Turnover | 1.14 | 1.31 | 0.93 | 1.11 | 1.08 | 0.98 |
Quick Ratio | 2.01 | 1.31 | 2.54 | 2.12 | 3.53 | 5.04 |
Current Ratio | 3.37 | 2.53 | 3.75 | 3.48 | 4.65 | 5.83 |
Return on Equity (ROE) | -53.92% | -49.31% | -35.20% | -13.67% | -16.61% | -16.75% |
Return on Assets (ROA) | -20.30% | -20.29% | -16.80% | -13.13% | -7.12% | -6.93% |
Return on Invested Capital (ROIC) | -62.55% | -59.89% | -52.62% | -44.23% | -30.84% | -24.36% |
Return on Capital Employed (ROCE) | -43.30% | -50.40% | -28.20% | -26.90% | -14.40% | -9.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -28.57% | -15.81% | -7.49% | -2.60% | -6.07% | -3.29% |
FCF Yield | -29.91% | -17.74% | -7.60% | -4.10% | -7.29% | -1.61% |
Dividend Yield | - | - | - | 0.26% | 0.86% | 0.62% |
Buyback Yield / Dilution | -4.29% | -7.02% | -11.05% | -0.53% | -2.77% | -17.10% |
Total Shareholder Return | -4.29% | -7.02% | -11.05% | -0.27% | -1.92% | -16.49% |